by Neoteryx | 4 min read
Routine blood testing is critical to identifying health problems early, and helping care providers make appropriate treatment interventions. That's why doctors recommend going for a blood test at least once …
Read Storyby Neoteryx | 3 min read
Veterinarians must respond to changing trends in pet ownership and pet care to help more pets get the care they deserve... A few years ago, pets were most likely to …
Read Storyby Neoteryx | 5 min read
Times have changed, and so has the average healthcare consumer. Today’s consumers are more inclined toward digital health solutions, particularly the younger generations. A survey from Accenture found millennials (born …
Read Storyby Neoteryx | 4 min read
What is occupational exposure? Millions of people are exposed to chemicals or other hazardous materials in their workplace every day. If not handled safely, these hazards can cause health problems …
Read Storyby Neoteryx | 3 min read
Advances in blood analysis technology enable researchers to identify possible biomarkers of health conditions before the onset of symptoms through a maternal fetal blood test. One such condition is pre-eclampsia …
Read Storyby Neoteryx | 3 min read
Alzheimer’s disease, the most common type of dementia, causes cognitive decline, mood and behavior changes, and memory loss. The leading cause of Alzheimer's disease (AD) is the accumulation of the 42-amino-acid-long …
Read StoryLearn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!
421 Amapola Ave
Torrance, CA 90501
Call us: 1 (310) 787-8747
info@neoteryx.com
The Mitra Device is a single-use, non-sterile device used as a specimen collector and for the storage and transport of blood or other biological fluids. It is designed to be used by laboratory and healthcare professionals, or end-users as a container to collect and transport blood or other biological fluids. It is not specific to any clinical test, and is not for use in diagnostic procedures. Use of the Mitra Microsampler in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with CLIA and/or other regulatory requirements.
The Mitra Microsampling Device is a FDA listed Class 1 exempt device, CE-IVD self-certified in the UK and EU, a Class I IVD in Australia, and registered with Health Canada. Neoteryx operates a Quality Management System (QMS) that is based on FDA good manufacturing practices, 21 CFR 820 regulations, and ISO-13485.
Copyright © 2019 Neoteryx, LLC. All rights reserved.